HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaughn, M. W. Articles by Haviland, D. L. Search for Related Content PubMed PubMed Citation Articles by Vaughn, M. W. Articles by Haviland, D. L.

Identification, Cloning, and Functional Characterization of a Murine Lipoxin A4 Receptor Homologue Gene¹

Institute of Molecular Medicine for the Prevention of Human Diseases, Research Center for Immunology and Autoimmune Diseases, University of Texas-Houston Health Science Center, Houston, TX.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
To identify additional members of the murine N-formyl-Met-Leu-Phe peptide receptor family (fMLF-R), a mouse macrophage cDNA library was screened using the open reading frame of murine N-formyl peptide receptor. Four individual hybridizing cDNA clones were maintained through tertiary screening. One cDNA clone was a truncated, polyadenylated version of the previously described murine-fMLF-R. The other three cDNA clones varied in length, but contained identical open reading frame sequences. One clone, 8C10, was selected for further study and shared 70% sequence identity with murine-fMLF-R and 89% sequence identity with murine lipoxin A4 receptor cDNA. When placed into the pcDNA-3 expression vector and cotransfected with G16 cDNA into COS-1 cells, 8C10 cDNA induced the production of inositol-1,4,5-triphosphate when concentrations of 1–1600 nM lipoxin A4 (LXA4) were tested as ligands. Northern blot analysis of murine organs indicated that the 8C10 message is present in lung, spleen, and adipose tissue. Moreover, mice treated with LPS demonstrated increased expression of 8C10 message in spleen and adipose tissue, while showing a slight reduction in lung. We have also characterized the 8C10 structural gene from a 129Sv/J genomic library and have determined its size to be >6.1 kb in length and comprised of two exons separated by a 4.8-kb intron. Collectively, these data indicate that this homologue receptor is closely related to the murine LXA4 receptor and functionally responds to LXA4 as a ligand.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
The directed migration of polymorphonuclear neutrophils can be mediated by a number of chemotactic factors that are released as a consequence of inflammation. Such factors include platelet-activating factor (1), leukotriene B4 (2), the anaphylatoxin complement fragment C5a (3), IL-8 (NAP-1/IL-8) (4), and N-formylated peptides (5, 6). In addition to chemotaxis, these factors mediate a variety of cellular and biochemical responses in neutrophils and macrophages. Such changes include bacteriocidal superoxide radical production, granule release of proteolytic enzymes, aggregation, and phagocytosis (reviewed by Snyderman and Pike (7)). These inflammatory factors mediate their responses through pertussis toxin-sensitive GTP-binding proteins, and the subsequent signal transduction can be abrogated by pertussis toxin (8, 9).

The high affinity human receptor for N-formyl peptides was cloned as two distinct cDNAs (R26 and R98) from a library prepared using dibutyryl cAMP-differentiated HL-60 cells (10, 11). The two cDNAs were found to be products of alternative polyadenlyation of transcripts derived from the same gene (12, 13, 14) and mapped to chromosome 19q.13.3 (13, 15). Differentiation of either U937 or HL-60 cells using dibutyryl cAMP produces additional, higher m.w. messages that hybridize to human N-formyl-Met-Leu-Phe peptide receptor (fMLF-R)³ cDNA by Northern analysis (13, 16). The expression of these additional messages probably represents the expression of structurally homologous genes related to fMLF-R. Two related genes were identified, termed formyl peptide receptor like-1 and -2, using the human fMLF-R cDNA probe under low stringency conditions (15). Currently, no ligand has been identified to bind the formyl peptide receptor like-2 receptor. However, Serhan and colleagues (17) identified the formyl peptide receptor like-1 receptor as the high affinity receptor for the anti-inflammatory ligand lipoxin A4.

Lipoxins are members of the eicosanoid family that can be generated either from single cells or during cell-to-cell interactions. In contrast to fMLF, lipoxin A4 (LXA4) has been shown to inhibit the chemotaxis of neutrophils toward leukotriene B4 as well as toward fMLF. In addition, LXA4 and lipoxin B4 (LXB4) have been found to inhibit fMLF-induced migration of neutrophils across intestinal epithelium (18) as well as reduce neutrophil adherence (by 70%) to HUVECs (19) and antagonize the mitogenic effects of leukotriene D4 (20) on renal mesangial cells. LXA4 and LXB4 have also been shown to down-regulate leukotriene-induced CD62P (P-selectin) expression on HUVECs (19) and reduce the cytolytic activity of NK cells (21). Additionally, LXA4 has been found to block airway constriction and promote vasodilation in asthmatic patients, suggesting their expression on lung epithelia and/or smooth muscle (22). It is likely that lipoxins may be the effectors of well-established anti-inflammatory therapies such as aspirin, which has been found to trigger the production of a modified form of LXA4 (recently reviewed in Ref. 23). This form, called 15-epimeric lipoxin, may mediate the beneficial effects of aspirin (24, 25, 26).

In an effort to determine whether additional members of the murine fMLF-R family exist, we screened a thioglycolate-stimulated murine macrophage cDNA library with the open reading frame of the murine fMLF-R using high stringency hybridization conditions. In these studies we have 1) identified a homologue of the previously identified murine LXA4 receptor (LXA4-R); 2) demonstrated that the cloned receptor can bind Lipoxin A4, suggesting that it may act as a second murine receptor for LXA4; 3) detected RNA expression of this receptor in adipose, lung, and spleen tissue derived from saline- and LPS-treated mice; and 4) determined that the this receptor is encoded by a two-exon structural gene analogous to other genes of the fMLF-R family.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Materials and reagents

Restriction enzymes and other molecular biology reagents were purchased from Roche (Indianapolis, IN) and used according to the manufacturer’s recommendations. Hybond-N⁺ nylon membranes and radionucleotides [-³²P]dCTP (3000 Ci/mmol) and myo-[³H]inositol (17 Ci/mmol) were purchased from Amersham (Arlington Heights, IL). Iodogen was purchased from Pierce (Rockford, IL). Sodium iodine [¹²⁵I] (3.7 Gbq/ml) was purchased from ICN (Costa Mesa, CA). N-formyl-Met-Leu-Phe (fMLF) and N-formyl-norLeu-Leu-Phe-norLeu-Tyr-Lys were purchased from Sigma (St. Louis, MO). LXA4 and LXB4 were purchased from Sigma and BIOMOL (Plymouth Meeting, PA).

Murine macrophage cDNA library screening

A Uni Zap XR mouse macrophage cDNA library constructed using mRNA isolated from B10.A thioglycolate-stimulated peritoneal macrophages was obtained from Stratagene (La Jolla, CA). Approximately 100,000 plaques were plated, and duplicate filters were screened with a random-primed (27) ³²P-labeled cDNA probe that was generated by PCR using oligonucleotides corresponding to the complete murine fMLF-R open reading frame (28). Duplicate filters were prehybridized and hybridized for 16 h at 65°C in a solution containing 5x SSC, 10x Denhardt’s solution, and 2.0% SDS, pH 7.4, washed at room temperature for 20 min and then at 65°C in 0.2x SSC containing 1.0% SDS, and exposed to autoradiography film (Amersham Hyperfilm MP) overnight at -70°C with intensifying screens. After identifying 10 fMLF-R-hybridizing clones, a second and a subsequent third set of filters were screened under identical conditions with the murine fMLF-R probe. Four of the original 10 clones carried in duplicate through tertiary screening were plaque purified, converted to p-Bluescript, and analyzed by restriction digestion and agarose gel electrophoresis.

Oligonucleotide synthesis and DNA sequence analysis

All oligonucleotides were synthesized using an Oligo 1000 M DNA Synthesizer (Beckman, Fullerton, CA). The oligonucleotides used as primers in the sequencing reactions were 20 mers. All cDNA and genomic sequencing was performed using double-stranded templates and a model 377A automated DNA sequencer from PE Applied Biosystems (Foster City, CA) according to the standard protocol of the Taq DyeDeoxy terminator cycle sequencing kit (PE Applied Biosystems), and sequencing was performed no less that three times on each strand. Derivation of consensus sequences and sequence analysis were conducted using MegAlign (DNAstar, Madison, WI). Additional protein/DNA comparisons were conducted using Bestfit (GCG, Madison, WI) and Vector NTI.

RNA analysis

BALB/c mice were injected i.p. with 200 µl saline alone or containing 10 µg sonicated endotoxin (LPS from Escherichia coli 0111:B4, phenol extract; Sigma). The animals were sacrificed by cervical dislocation 24 h later, and tissues were removed, snap-frozen in liquid nitrogen, and stored at -70°C. Frozen tissues were pulverized in liquid nitrogen, and total RNA was extracted by lysis with guanidinium isothiocyanate and cesium chloride density gradient ultracentrifugation (29). RNA was quantified by absorbance at 260 nm, subjected to electrophoresis on 1.2% agarose formaldehyde gels, transferred to Hybond-N⁺ using the method described by Virca et al. (30), and probed with a random-primed labeled murine fMLF-R PCR open reading frame (ORF) fragment.

Transfection and displacement binding assays

The coding sequence of the murine fMLF-R and LXA4-R homologue cDNAs were excised from the p-Bluescript vectors using XbaI and XhoI. Inserts were isolated, blunt end-filled, and ligated into the EcoRV site of the mammalian expression vector pcDNA3 (Invitrogen, San Diego, CA). Human fMLF-R cDNA (13) was removed from p-Bluescript using HindIII and XbaI and placed into pcDNA-3 using the same enzymes. The correct orientation and nucleotide sequence of the expression clones (pcDNA3. 8C10, and UF1) (13) were confirmed by DNA sequence analysis. Monolayers of stable transfected cells were seeded overnight (10⁶/well) into six-well plates (Corning, Corning, NY). N-formyl-Nle-Leu-Phe-norLeu-Tyr-Lys was iodinated using Iodogen (Pierce, Rockford, IL). Radiolabeled [¹²⁵I]N-formyl-Nle-Leu-Phe-norLeu-Tyr-Lys (5 nM) was incubated on the cells the next day for 45 min at 37°C in a 1-ml total volume of binding medium (DMEM, 1 mg/ml BSA, 0.05% Tween 80, and 10 mM HEPES, pH 7.2) in the absence or the presence of increasing concentrations of fMLF. After the incubation period, cells were gently washed three times in binding medium and solubilized in 1 N NaOH, and counts per minute were determined using a Packard Cobra gamma counter (Meriden, CT).

Expression studies and phospholipase C assays

Measurement of phospholipase C-catalyzed inositol phosphate formation was performed as previously described (31). Briefly, cells were seeded in 12-well plates at a density of 6.5 x 10⁴ cells/well. Transfections into COS-1 cells with various cDNAs alone or in combination with an expression vector encoding the G16 cDNA (a gift from Dr. M. Lui, IBT-Texas A&M, Houston, TX) were conducted using Lipofectamine (Life Technologies, Gaithersburg, MD) (32). Cells were labeled for 20–24 h with 8 µCi/ml myo-[³H]inositol in DMEM with 10% dialyzed FBS. Cells were then washed with PBS and incubated in complete medium containing 10 mM LiCl at 37°C for 25 min. Various ligands were added (as indicated in the figures), and incubation proceeded at 37°C for 20 min. The cells were lysed in ice-cold 15 mM formic acid for 30 min on ice; the lysates were then neutralized with 20 mM NH₄OH. Total inositol phosphates were separated on an anion exchange column (AG-1, Bio-Rad), washed with 5 mM borax/60 mM sodium formate, and eluted with 1 M ammonium formate/0.1 M formic acid. Triplicate samples were counted by scintillation spectrophotometry and are representative of three separate experiments. All data were analyzed and plotted using PRISM 3.0 (GraphPad, Berkeley, CA).

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Isolation of cDNA clones related to the murine fMLF-R

Using synthetic oligonucleotides, the open reading frame of the murine fMLF-R was amplified by PCR using DBA/1 genomic DNA as template. The PCR product encoding the murine fMLF-R was subcloned into pcDNA-3, and the identity was confirmed by sequencing. It was subsequently used as a probe to screen a B10.A thioglycolate-stimulated peritoneal macrophage cDNA library. Ten primary isolates from 100,000 original clones were picked and rescreened under identical conditions. Four of the original 10 clones were taken to single colony isolates. These four phage clones were turned into plasmids, sequenced with vector-based oligonucleotides, and analyzed. A single clone partially encoded the cDNA for the murine fMLF-R described by Gao and Murphy (28). This cDNA clone was truncated at position 748 of the open reading frame (at Arg²⁶¹) and polyadenylated.

In addition, we obtained three clones that were different from the murine fMLF-R. Although these three clones varied in overall length, all had putative open reading frames that were identical and shared 70% sequence identity with the murine fMLF-R. One clone, called 8C10, was chosen for further study, and its complete sequence was determined (Fig. 1). The 8C10 cDNA consists of 1179 bp (not including the poly(A)⁺ tail) and encodes 351 aa.

View larger version (45K): [in this window] [in a new window]   FIGURE 1. The nucleotide and derived protein sequences of the murine LXA4-R homologue (8C10). The 8C10 cDNA consists of 1179 bp (not including the poly(A)+ tail) and encodes an ORF (1056 bp) for 351 aa with an estimated unglycosylated Mr of 39,421 Da. The selection of amino acids was made using mammalian codons, and the stop codon (TGA) is indicated by the asterisk.

A 129Sv/j phage genomic library was screened for LXA4-R homologue (8C10) genomic clones under high stringency using the 8C10 ORF cDNA as a probe. One hybridizing phage clone was identified, and the colony was purified. The DNA that was isolated from this clone was digested with the enzymes BamHI, EcoRI, HindIII, SacI, XbaI, and XhoI. A Southern blot analysis revealed that two hybridizing EcoRI bands probably contain the 8C10 gene. These two bands (1Eco6, at 6.3 kb and 1Eco4 at 4.1 kb) were isolated and subcloned into p-Bluescript KS-II⁺. The sequence of the murine LXA4-R homologue (8C10) structural gene, intron-exon boundaries, and exon sequence were determined by DNA sequence analysis, employing synthetic oligonucleotides as primers. The results of the mapping data are shown in Fig. 2. The murine LXA4-R homologue structural gene (7.5 kb) is encoded by only two exons. By assigning nucleotide position 1 as the 5' end of the 8C10 cDNA, exon 1 encodes 18 bp of 5'-untranslated sequence, while exon 2 encodes 10 bp of 5'-untranslated sequence, the murine LXA4-R homologue (8C10) ORF, and 3'-untranslated sequences. Exons 1 and 2 are separated by a 4836-bp intron.

View larger version (7K): [in this window] [in a new window]   FIGURE 2. Structural organization of the murine LXA4 receptor homologue (8C10) gene. The isolated phage clone containing the 8C10 gene was digested with EcoRI, and the two bands identified by Southern analysis that hybridized to the 8C10 cDNA were subcloned into p-Bluescript SK-II+ and sequenced using synthetic oligonucleotides as primers. The 1Eco6 fragment was completely sequenced using PCR-based cycle sequencing as described in Materials and Methods. , Coding region is shown as a shaded box; , 5'- and 3'-untranslated regions.

View larger version (30K): [in this window] [in a new window]   FIGURE 3. Nucleotide sequence of the putative 5'-flanking region of the murine LXA4-R homologue (8C10) structural gene. The sequence shown is derived from an EcoRI (1Eco6)-subcloned fragment derived from the genomic phage clone. Exon 1 is shown in uppercase letters, and the 5'-flanking sequence is shown in lowercase letters. The beginning of the cDNA is denoted +1. Sequences that correspond to identified consensus sequences are boxed and identified as shown above.

Tissue expression of the LXA4-R (8C10) homologue

To determine the tissue distribution of the murine LXA4-R homologue, an RNA hybridization analysis was conducted using tissues from both saline- and LPS-treated mice, with the radiolabeled 8C10 cDNA ORF as a probe. A variety of LPS- and saline-treated tissues were examined, including adipose, brain, heart, kidney, lung, large intestine, small intestine, liver, and spleen. Of these tissues, only RNA derived from spleen, lung, and adipose tissue hybridized to the murine LXA4-R homologue ORF, as shown in Fig. 4. Basal expression was found in murine lung, spleen, and adipose tissue; however, with LPS treatment, a marked increase in the LXA4-R homologue expression was noted, particularly in lung and adipose tissue. In tissues expressing the LXA4-R homologue RNA, two hybridizing bands were detected. This is possibly due to 1) alternative processing of the 8C10 mRNA in these tissues, or 2) cross-hybridization to the murine LXA4-R or some other unidentified homologue. For the second case to be true, this would indicate that the two genes are regulated identically, which, although possible, is unlikely. The most reasonable explanation is that the two bands are derived from alternative processing of the 8C10 message.

View larger version (38K): [in this window] [in a new window]   FIGURE 4. Northern blot analysis of total RNA from murine tissues. Ten micrograms of RNA isolated from the indicated murine tissues was subjected to denaturing agarose gel electrophoresis and Northern blot analysis as described in Materials and Methods. The blot was probed with a 32P-labeled, random-primed 8C10 cDNA PCR fragment. The murine tissues were derived from BALB/c mice that had been injected (i.p.) with either saline or LPS as described in Materials and Methods. The blot was exposed to Hyperfilm for 18 h at 70°C. All RNA samples were equally loaded, as determined by ethidium staining (data not shown).

The 8C10 cDNA was excised from p-Bluescript and then placed into the mammalian expression vector pCDNA-3. HEK-293 cells were transfected and cultured under neomycin (G418) selection. When [¹²⁵I]fMLF radiolabeled ligand (N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys) displacement assays were conducted, it was determined that the protein translated from the 8C10 message did not bind labeled fMLF, whereas cells transfected with human fMLF-R demonstrated binding in a displacement assay shown in Fig. 5. [¹²⁵I]N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys (5 nM) was applied to HEK cells or to HEK cells that were stably transfected with 8C10 cDNA or cDNA encoding human fMLF-R. Neither HEK nor the HEK 8C10 transfectants demonstrated binding of the radiolabeled ligand. Only HEK cells expressing human fMLF-R cDNA demonstrated binding of the labeled ligand and subsequent displacement using unlabeled fMLF. Given the marked primary DNA and amino acid sequence identity that exists between 8C10 protein sequence and that of the murine LXA4-R, we tested the expressed 8C10 for biological activity with LXA4 as ligand using a phospholipase C assay. COS cells were cotransfected with cDNAs alone or in combination. As shown in Fig. 6, the protein encoded by the 8C10 cDNA was capable of responding to LXA4 ligand, as shown by the increased incorporation of [³H]inositol over the tested range of 1–1600 nM (groups A and B). In addition, the response to LXA4 was specific, as no incorporation of inositol-1,4,5-triphosphate was observed with 8C10 cDNA in the absence of the cotransfected G16 expression vector (group A). LXA4 also induced the incorporation of inositol when the expression vector containing cDNA encoding murine LXA4-R (a gift from Dr. C. Serhan) was cotransfected with the G16 expression vector (group C). Two irrelevant ligands, the complement anaphylatoxins C3a and C5a, were tested in the assay at a single dose of 400 nM and did not elicit a response in COS cells transfected with the 8C10 cDNA (group D). These functional data along with the sequence data have lead us to conclude that the 8C10 clone encodes a murine LXA4-R homologue that responds to LXA4.

View larger version (14K): [in this window] [in a new window]   FIGURE 5. Displacement binding of [125I]N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys to HEK-293 cells alone or to cells separately transfected with 8C10 (murine LXA4-R homologue) cDNA or human fMLF-R cDNA. Radiolabeled [125I]N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys (5 nM) was incubated with the cells in the presence of unlabeled fMLF. Data points were obtained in triplicate, and error bars are contained within the size of the symbols.

View larger version (28K): [in this window] [in a new window]   FIGURE 6. Accumulation of [3H]inositol phosphates in COS-1 cells transfected with the murine LXA4-R homologue (8C10) cDNA. Cells were transfected with eukaryotic expression vectors encoding the cDNAs for -galactosidase (pSV-Gal) and the murine LXA4-R homologue (8C10) either alone or with G16, labeled, washed, and stimulated with various concentrations of LXA4 (A and B) and with complement anaphylatoxins C3a and C5a (C) as described in Materials and Methods. Levels of inositol phosphates were determined as described. Shown are the mean and SE of triplicate determinations from a representative experiment. Significant differences between the G16 control and those with G16 and the murine LXA4-R homologue (8C10) are indicated (p < 0.05, determined by unpaired Student’s t test).

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

LXA4 and LXB4 are members of the eicosanoid family. Lipoxins are formed by the metabolism of arachidonic acid by lipoxigenases during cell-cell interactions and are rapidly metabolized in vivo. Lipoxin biosynthesis has also been shown to occur in many human diseases (reviewed in Ref. 23) and serve as braking or stop signals for the proinflammatory actions of neutrophils. Peripheral blood monocytes have been found to metabolize lipoxins during inflammation, thrombosis, and atherosclerosis (39, 40). In contrast to neutrophils, lipoxins activate monocytes, inducing their migration to sites of inflammation where they play a role in wound healing (41). Finally, Godsen et al. (42) recently demonstrated that lipoxins are capable of stimulating human macrophages to phagocytose apoptotic neutrophils.

Although interaction of fMLF and lipoxin with their respective receptors have functionally opposite roles in the inflammatory process, their receptors share numerous structural characteristics. Both are members of the rhodopsin superfamily, traverse the membrane seven times, and are coupled to pertussis toxin-sensitive, GTP binding proteins (8, 17). Another characteristic of this superfamily is a very simple gene structure comprised of only two exons. Moreover, human and murine fMLF-R and LX A4-R share surprising 76 and 70% identities at the nucleotide level, respectively.

Although not exhaustive, the screening of the murine thioglycolate-elicited macrophage cDNA library did not produce any clones identical with the murine LXA4-R (Fpr-rs1) as described by Takano et al. (24) and Gao et al. (43). From the four phage clones identified, three clones varied in overall length, but had identical ORFs encoding the murine LXA4-R homologue (8C10) described here. The fourth phage clone encoded cDNA for the murine fMLF-R described by Gao and Murphy (28) that was truncated and polyadenylated at position 748 of the ORF (Arg²⁶¹).

The nucleotide and amino acid identity between murine LXA4-R and the LXA4-R homologue is striking (89%). In comparing the ORFs, the first 435 bp between these two receptors are identical. The sequence progressively diverges in the latter half of the sequence between these two genes. This identity is summarized in Fig. 6, which depicts both the nucleotide and amino acid sequence identities among the extracellular, intercellular, and transmembrane regions. Initially, we thought that the 8C10 clone was an allelic variant of the murine LXA4-R, but with further examination of both the nucleotide and peptide sequences, we concluded that the murine LXA4 and LXA4 homologue receptors are encoded by separate genes and are not allelic variants. This has been confirmed using the Ensembl mouse genome databases, which show that these two genes are separately contained on mouse chromosome 17 (http://www.ensembl.org/mus_musculus/data_release.html) (44).

Of particular interest was the tissue expression of the LXA4-R homologue on both saline- and LPS-treated murine tissues (Fig. 4). Lung and spleen tissues obtained from saline-treated mice demonstrated a detectable, but low level, expression of the LXA4-R homologue message, which was markedly increased in mice treated with LPS. This finding was not unexpected given the inflammatory response induced by LPS and that receptors for lipoxins have been found primarily on neutrophils and macrophages. The surprising result was finding the LXA4-R homologue message in adipose tissue in both saline- and LPS-treated mice. It was noted that two bands were observed in each of the tissues that hybridized with the 8C10 cDNA. Collectively, these results are intriguing, but they are limited until immunohistochemistry and/or in situ hybridization studies are conducted to ascertain whether the tissue itself is expressing the LXA4-R homologue or if the signal is due to resident or infiltrating myeloid cells, as may be the case with lung and splenic tissues.

During our studies of the 8C10 gene, Gao et al. (43) expanded the murine fMLF-R family to include the murine fMLF-R (FPR1) and five homologues, termed Fpr-rs1 through Fpr-rs5. The murine LXA4-R identified by Takano et al. (24) is identical with the Fpr-rs1 identified by Gao et al. (43). The LXA4-R homologue (8C10) described in this report is identical with Fpr-rs2. In their report Fpr-rs2 (8C10) was described as a possible low affinity fMLF receptor homologue, and at that time the response of this receptor to LXA4 was not considered. Based on our current data it appears more likely that 8C10 is in fact an LXA4-R homologue.

In conclusion, the study of both pro- and anti-inflammatory receptors provides a unique opportunity to examine how the inflammatory response is mediated and modulated. Understanding the biology and biochemistry of both types of receptors will provide insights into processes involved in switching the cellular response from pro- to anti-inflammatory. In addition, understanding the similarities and differences in the biochemistry of pro- and anti-inflammatory signal transduction may provide venues for future therapeutic approaches.

View larger version (19K): [in this window] [in a new window]   FIGURE 7. Nucleic and amino acid percent identities between murine LXA4-R and the murine LXA4-R homologue (8C10). Shown is a schematic of a seven-transmembrane receptor representing both the previously described murine LXA4-R (24 ) and the LXA4-R homologue (8C10) presently described. Shown adjacent to the extracellular, intracellular, and transmembrane domains are the percentages of nucleic acid (numbers above) and amino acid (numbers below in parentheses) identities between these two related receptors.

	Acknowledgments

	Footnotes

 
¹ This work was supported by U.S. Public Health Services Grant GM56050 (to D.L.H.). Sequence data from this article have been deposited with the EMBL/GenBank Data Libraries under accession no. AY138248.

² Address correspondence and reprint requests to Dr. David L. Haviland, Institute of Molecular Medicine for the Prevention of Human Diseases, Research Center for Immunology and Autoimmune Diseases, University of Texas-Houston Health Science Center, 2121 West Holcombe Boulevard, Houston, TX 77030. E-mail address: david.l.haviland{at}.uth.tmc.edu

³ Abbreviations used in this paper: fMLF-R, N-formyl-Met-Leu-Phe peptide receptor; fMLF, N-formyl-Met-Leu-Phe; LXA4, lipoxin A4; LXA4-R, LXA4 receptor; LXB4, lipoxin B4; ORF, open reading frame.<./>

Received for publication March 15, 2002. Accepted for publication July 24, 2002.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Hanahan, D. J.. 1986. Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55:483.[Medline]
2. Goldman, D. W., E. J. Goetzl. 1982. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J. Immunol. 129:1600.[Abstract]
3. Chenoweth, D. E., T. E. Hugli. 1980. Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol. Immunol. 17:151.[Medline]
4. Baggiolini, M., A. Walz, S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045.
5. Marasco, W. A., S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker, P. A. Ward. 1984. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259:5430.[Abstract/Free Full Text]
6. Schiffmann, E., B. A. Corcoran, S. M. Wahl. 1975. N-formylmethionyl peptides as chemoattractants for leukocytes. Proc. Natl. Acad. Sci. USA 72:1059.[Abstract/Free Full Text]
7. Snyderman, R., M. C. Pike. 1984. Chemoattractant receptors on phagocytic cells. Annu. Rev. Immunol. 2:257.[Medline]
8. Bokoch, G. M., A. G. Gilman. 1984. Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin. Cell 39:301.[Medline]
9. Bokoch, G. M., U. G. Knaus. 1994. The role of small GTP-binding proteins in leukocyte function. Curr. Opin. Immunol. 6:98.[Medline]
10. Boulay, F., M. Tardif, L. Brouchon, P. Vignais. 1990. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Commun. 168:1103.[Medline]
11. Murphy, P. M., D. McDermott. 1991. Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor. J. Biol. Chem. 266:12560.[Abstract/Free Full Text]
12. Perez, H. D., R. Holmes, E. Kelly, J. McClary, Q. Chou, W. H. Andrews. 1992. Cloning of the gene coding for a human receptor for formyl peptides, characterization of a promoter region and evidence for polymorphic expression. Biochemistry 31:11595.[Medline]
13. Haviland, D. L., A. C. Borel, D. T. Fleischer, J. C. Haviland, R. A. Wetsel. 1993. Structure, 5' flanking sequence and chromosome location of the human n-formyl peptide receptor gene: a single copy gene comprised of two exons on chromosome 19q13.3 that yields two distinct transcripts by alternative polyadenylation. Biochemistry 32:4168.[Medline]
14. Murphy, P. M., H. L. Tiffany, D. McDermott, S. K. Ahuja. 1993. Sequence and organization of the human N-formyl peptide receptor-encoding gene. Gene 133:285.[Medline]
15. Bao, L., N. P. Gerard, Jr R. L. Eddy, T. B. Shows, C. Gerard. 1992. Mapping of genes for the human C5a receptor (C5aR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13:437.[Medline]
16. Boulay, F., M. Tardif, L. Brouchon, P. Vignais. 1990. The human n-formylpeptide receptor: characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29:11123.[Medline]
17. Fiore, S., J. F. Maddox, H. D. Perez, C. N. Serhan. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A₄ receptor. J. Exp. Med. 180:253.[Abstract/Free Full Text]
18. Colgan, S. P., C. N. Serhan, C. A. Parkos, C. Delp-Archer, J. L. Madara. 1993. Lipoxin A₄ modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92:75.
19. Papayianni, A., C. N. Serhan, H. R. Brady. 1996. Lipoxin A₄ and B₄ inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156:2264.[Abstract]
20. McMahon, B., C. Stenson, F. McPhillips, A. Fanning, H. R. Brady, C. Godson. 2000. Lipoxin A₄ antagonized the mitogenic effects of leukotriene D₄ in human renal mesangial cells. J. Biol. Chem. 275:27566.[Abstract/Free Full Text]
21. Ramstedt, U., C. N. Serhan, K. C. Nicolaou, S. E. Webber, H. Wigzell, B. Samuelsson. 1987. Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on steriospecificity of inhibition and mode of action. J. Immunol. 138:266.[Abstract]
22. Christie, P. E., B. W. Spur, T. H. Lee. 1992. The effects of lipoxin A₄ on airway responses in asthmatic subjects. Am. Rev. Respir. Dis. 145:1281.[Medline]
23. McMahon, B., S. Mitchell, H. R. Brady, C. Godson. 2001. Lipoxins: revelations on resolution. Trends Pharm. Sci. 22:391.[Medline]
24. Takano, T., S. Fiore, J. F. Maddox, H. R. Brady, N. A. Petasis, C. N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A₄ (LXA₄) and LXA₄ stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693.[Abstract/Free Full Text]
25. Clària, J., C. N. Serhan. 1995. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 92:9475.[Abstract/Free Full Text]
26. Goh, M., A. W. Baird, C. O’Keane, R. W. G. Watson, D. Cottell, G. Bernasconi, N. A. Petasis, C. Godson, H. R. Brady, P. MacMathuna. 2001. Lipoxin A₄ and aspirin-triggered 15-epi-lipoxin A₄ antagonize TNF--stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF--induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. J. Immunol. 167:2772.[Abstract/Free Full Text]
27. Feinberg, A. P., B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6.[Medline]
28. Gao, J. L., P. M. Murphy. 1993. Species and subtype variants of the n-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 268:25395.[Abstract/Free Full Text]
29. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.[Medline]
30. Virca, G. D., W. Northemann, B. R. Shiels, G. Widera, S. Broome. 1990. Simplified Northern blot hybridization using 5% sodium dodecyl sulfate. BioTechniques 8:370.[Medline]
31. Liu, M., M. I. Simon. 1996. Regulation by cAMP-dependent protein kinase of a G-protein-mediated phospholipase C. Nature 382:83.[Medline]
32. Baker, E. A., M. W. Vaughn, D. L. Haviland. 2000. Choices in transfection methodologies: transfection efficiency should not be the sole criterion. Focus 22:31.
33. Jones, K. A., K. R. Yamamoto, R. Tjian. 1985. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell 42:559.[Medline]
34. Jones, K. A., J. T. Kadonaga, P. J. Rosenfeld, T. J. Kelly, R. Tjian. 1988. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:79.
35. Gourdon, G., F. Morle, J. Roche, N. Tourneur, V. Joulain, J. Godet. 1992. Identification of GATA-1 and NF-E2 binding sites in the flanking region of the human -globin genes. Acta Haematol. 87:804.
36. Kollmar, R., P. J. Farnham. 1993. Site-specific initiation of transcription by RNA polymerase II. Proc. Soc. Exp. Biol. Med. 203:127.[Medline]
37. Hattori, M., L. J. Abraham, W. Nothemann, G. W. Fey. 1990. Acute-phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin 6 response element of the rat ₂-macroglobulin gene. Proc. Natl. Acad. Sci. USA 87:2364.[Abstract/Free Full Text]
38. Sen, R., D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.[Medline]
39. Serhan, C. N.. 1994. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta 1212:1.[Medline]
40. Brezinski, D. A., R. W. Nesto, C. N. Serhan. 1992. Angioplasty triggers intracoronary leukotrienes and lipoxin A₄: impact of aspirin therapy. Circulation 86:56.[Abstract/Free Full Text]
41. Maddox, J. F., C. N. Serhan. 1996. Lipoxin A₄ and B₄ are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehyrogenation and reduction. J. Exp. Med. 183:137.[Abstract/Free Full Text]
42. Godson, C., S. Mitchell, K. Harvey, N. A. Petasis, N. Hogg, H. R. Brady. 2000. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164:1663.[Abstract/Free Full Text]
43. Gao, J. L., J. Chen, J. D. Filie, C. A. Kozak, P. M. Murphy. 1998. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51:270.[Medline]
44. Hubbard, T., D. Barker, E. Birney, G. Cameron, Y. Chen, L. Clark, T. Cox, J. Cuff, V. Curwen, T. Down, et al 2002. The Ensembl genome database project. Nucleic Acids Res. 30:38.[Abstract/Free Full Text]
45. Gronert, K., A. Gewirtz, J. L. Madara, C. N. Serhan. 1998. Identification of a human enterocyte lipoxin A₄ receptor that is regulated by interleukin (IL)-13 and interferon- and inhibits tumor necrosis factor -induced IL-8 release. J. Exp. Med. 187:1285.[Abstract/Free Full Text]

This article has been cited by other articles:

				R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161. [Abstract] [Full Text] [PDF]

				B. A. Babbin, M. G. Laukoetter, P. Nava, S. Koch, W. Y. Lee, C. T. Capaldo, E. Peatman, E. A. Severson, R. J. Flower, M. Perretti, et al. Annexin A1 Regulates Intestinal Mucosal Injury, Inflammation, and Repair J. Immunol., October 1, 2008; 181(7): 5035 - 5044. [Abstract] [Full Text] [PDF]

				E. L. Southgate, R. L. He, J.-L. Gao, P. M. Murphy, M. Nanamori, and R. D. Ye Identification of Formyl Peptides from Listeria monocytogenes and Staphylococcus aureus as Potent Chemoattractants for Mouse Neutrophils J. Immunol., July 15, 2008; 181(2): 1429 - 1437. [Abstract] [Full Text] [PDF]

				J.-L. Gao, A. Guillabert, J. Hu, Y. Le, E. Urizar, E. Seligman, K. J. Fang, X. Yuan, V. Imbault, D. Communi, et al. F2L, a Peptide Derived from Heme-Binding Protein, Chemoattracts Mouse Neutrophils by Specifically Activating Fpr2, the Low-Affinity N-Formylpeptide Receptor J. Immunol., February 1, 2007; 178(3): 1450 - 1456. [Abstract] [Full Text] [PDF]

				K. Wada, M. Arita, A. Nakajima, K. Katayama, C. Kudo, Y. Kamisaki, and C. N. Serhan Leukotriene B4 and lipoxin A4 are regulatory signals for neural stem cell proliferation and differentiation FASEB J, September 1, 2006; 20(11): 1785 - 1792. [Abstract] [Full Text] [PDF]

				N. Chiang, C. N. Serhan, S.-E. Dahlen, J. M. Drazen, D. W. P. Hay, G. E. Rovati, T. Shimizu, T. Yokomizo, and C. Brink The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo Pharmacol. Rev., September 1, 2006; 58(3): 463 - 487. [Abstract] [Full Text] [PDF]

				P. Iribarren, K. Chen, J. Hu, X. Zhang, W. Gong, and J. M. Wang IL-4 Inhibits the Expression of Mouse Formyl Peptide Receptor 2, a Receptor for Amyloid {beta}1-42, in TNF-{alpha}-Activated Microglia J. Immunol., November 1, 2005; 175(9): 6100 - 6106. [Abstract] [Full Text] [PDF]

				H. Rompler, A. Schulz, C. Pitra, G. Coop, M. Przeworski, S. Paabo, and T. Schoneberg The Rise and Fall of the Chemoattractant Receptor GPR33 J. Biol. Chem., September 2, 2005; 280(35): 31068 - 31075. [Abstract] [Full Text] [PDF]

				T. Ohira, G. Bannenberg, M. Arita, M. Takahashi, Q. Ge, T. E. Van Dyke, G. L. Stahl, C. N. Serhan, and J. A. Badwey A Stable Aspirin-Triggered Lipoxin A4 Analog Blocks Phosphorylation of Leukocyte-Specific Protein 1 in Human Neutrophils J. Immunol., August 1, 2004; 173(3): 2091 - 2098. [Abstract] [Full Text] [PDF]

				Y. Le, P. Iribarren, W. Gong, Y. Cui, X. Zhang, and J. M. Wang TGF-{beta}1 Disrupts Endotoxin Signaling in Microglial Cells through Smad3 and MAPK Pathways J. Immunol., July 15, 2004; 173(2): 962 - 968. [Abstract] [Full Text] [PDF]

				B. McMahon and C. Godson Lipoxins: endogenous regulators of inflammation Am J Physiol Renal Physiol, February 1, 2004; 286(2): F189 - F201. [Abstract] [Full Text] [PDF]

				C. Bonnans, B. Mainprice, P. Chanez, J. Bousquet, and V. Urbach Lipoxin A4 Stimulates a Cytosolic Ca2+ Increase in Human Bronchial Epithelium J. Biol. Chem., March 21, 2003; 278(13): 10879 - 10884. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaughn, M. W. Articles by Haviland, D. L. Search for Related Content PubMed PubMed Citation Articles by Vaughn, M. W. Articles by Haviland, D. L.